| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.1M | -82.7% |
| R&D Expense | $80.3M | +30.8% |
| SG&A Expense | $32.9M | +17.5% |
| Operating Income | -$110.0M | -54.3% |
| Income Tax | $0 | — |
| Net Income | -$107.5M | -50.7% |
| EPS (Basic) | -$3.32 | -29.2% |
| EPS (Diluted) | -$3.32 | -29.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $52.4M | -65.8% |
| Short-term Investments | $161.2M | +70.1% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $220.5M | -14.0% |
| Total Assets | $261.8M | -25.9% |
| Current Liabilities | $15.7M | -3.7% |
| Total Liabilities | $30.5M | -11.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$86.7M | -25.4% |
| Capital Expenditures | $11.5M | +26.6% |
| Investing Cash Flow | -$17.1M | +90.1% |
| Financing Cash Flow | $3.1M | -97.4% |
| Free Cash Flow | -$98.2M | -25.5% |
| Stockholders' Equity |
| $231.3M |
| -27.5% |